Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Touyun Biotech Group Limited per 2025 Jun 30 adalah 143.61 MM.
- Nilai operating income untuk Touyun Biotech Group Limited per 2025 Jun 30 adalah -56.29 MM.
- Nilai net income untuk Touyun Biotech Group Limited per 2025 Jun 30 adalah -28.89 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 143.61 | -56.29 | -28.89 |
2025-03-31 | 151.79 | -51.47 | -58.50 |
2024-12-31 | 159.97 | -46.66 | -88.11 |
2024-09-30 | 164.75 | -68.67 | -160.53 |
2024-06-30 | 169.54 | -90.69 | -232.96 |
2024-03-31 | 184.09 | -90.42 | -250.95 |
2023-12-31 | 198.64 | -90.15 | -268.94 |
2023-09-30 | 225.77 | -75.71 | -231.44 |
2023-06-30 | 252.90 | -61.27 | -193.95 |
2023-03-31 | 284.36 | -51.87 | -196.01 |
2022-12-31 | 315.82 | -42.47 | -198.06 |
2022-09-30 | 314.43 | -39.54 | -148.85 |
2022-06-30 | 313.04 | -36.62 | -99.64 |
2022-03-31 | 298.27 | -37.39 | -86.30 |
2021-12-31 | 283.50 | -38.15 | -72.95 |
2021-09-30 | 267.84 | -38.72 | -110.44 |
2021-06-30 | 252.18 | -39.30 | -147.93 |
2021-03-31 | 229.49 | -47.08 | -158.35 |
2020-12-31 | 206.79 | -54.86 | -168.78 |
2020-09-30 | 229.60 | -51.62 | -190.28 |
Laporan Laba Rugi: EPS
- earnings per share basic untuk Touyun Biotech Group Limited pada 2025 Jun 30 adalah -0.01.
- laba per saham yang terdilusi untuk Touyun Biotech Group Limited pada 2025 Jun 30 adalah -0.01.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | -0.01 | -0.01 |
2025-03-31 | -0.02 | -0.02 |
2024-12-31 | -0.03 | |
2024-09-30 | -0.06 | -0.06 |
2024-06-30 | -0.08 | -0.08 |
2024-03-31 | -0.09 | -0.09 |
2023-12-31 | -0.10 | |
2023-09-30 | -0.08 | -0.08 |
2023-06-30 | -0.07 | -0.07 |
2023-03-31 | -0.07 | -0.07 |
2022-12-31 | -0.07 | |
2022-09-30 | -0.05 | -0.05 |
2022-06-30 | -0.04 | -0.04 |
2022-03-31 | -0.03 | -0.03 |
2021-12-31 | -0.03 | |
2021-09-30 | -0.04 | -0.04 |
2021-06-30 | -0.05 | -0.05 |
2021-03-31 | -0.06 | -0.06 |
2020-12-31 | -0.06 | |
2020-09-30 | -0.07 | -0.07 |
Arus Kas: Operasi, Investasi, Pendanaan
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | -49.87 | -4.66 | 35.74 |
2024-09-30 | -48.25 | -10.18 | 34.76 |
2024-06-30 | -45.16 | -15.70 | 32.32 |
2024-03-31 | -20.76 | -43.32 | 2.32 |
2023-12-31 | 2.18 | -70.95 | -26.21 |
2023-09-30 | 25.56 | -71.93 | -1.36 |
2023-06-30 | 48.93 | -72.92 | 23.50 |
2023-03-31 | 11.28 | -45.08 | 63.06 |
2022-12-31 | -26.37 | -17.25 | 102.63 |
2022-09-30 | 4.64 | -25.52 | 28.59 |
2022-06-30 | 35.65 | -33.80 | -45.44 |
2022-03-31 | -9.08 | -90.77 | 38.86 |
2021-12-31 | -53.81 | -147.74 | 123.17 |
2021-09-30 | -128.19 | -145.53 | 212.16 |
2021-06-30 | -202.56 | -143.33 | 301.15 |
2021-03-31 | -108.95 | -95.60 | 230.81 |
2020-12-31 | -15.35 | -47.87 | 160.47 |
2020-09-30 | -51.33 | 21.95 | 111.30 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/e untuk Touyun Biotech Group Limited pada 2025 Jun 30 adalah -2.58.
- p/libro untuk Touyun Biotech Group Limited pada 2025 Jun 30 adalah -5.59.
- p/tbv untuk Touyun Biotech Group Limited pada 2025 Jun 30 adalah -2.73.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -2.58 | -5.59 | -2.73 |
2025-03-31 | -5.70 | -12.36 | -12.36 |
2024-12-31 | -2.17 | -19.75 | -19.75 |
2024-09-30 | -2.04 | -18.54 | -18.54 |
2024-06-30 | -1.88 | 23.97 | 23.97 |
2024-03-31 | -2.19 | 27.96 | -694.87 |
2023-12-31 | -3.43 | 3.26 | 3.26 |
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | -25.02 | 5.98 | 6.07 |
2021-09-30 | -16.30 | 3.89 | 3.95 |
2021-06-30 | -10.23 | 2.44 | 2.48 |
2021-03-31 | -9.46 | 2.42 | 2.46 |
2020-12-31 | -8.87 | 2.69 | 2.74 |
2020-09-30 | -7.87 | 2.69 | 2.74 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Touyun Biotech Group Limited pada 2025 Jun 30 adalah -0.14.
- EBIT (3 tahun) / EV untuk Touyun Biotech Group Limited pada 2025 Jun 30 adalah -0.28.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.14 | -0.28 |
2025-03-31 | -0.10 | -0.20 |
2024-12-31 | -0.27 | -0.27 |
2024-09-30 | -0.28 | -0.25 |
2024-06-30 | -0.24 | -0.18 |
2024-03-31 | -0.27 | -0.15 |
2023-12-31 | -0.16 | -0.14 |
2023-09-30 | -0.14 | -0.12 |
2023-06-30 | -0.11 | -0.09 |
2023-03-31 | -0.09 | -0.05 |
2022-12-31 | -0.08 | -0.10 |
2022-09-30 | -0.06 | -0.07 |
2022-06-30 | -0.05 | -0.07 |
2022-03-31 | 0.00 | -0.05 |
2021-12-31 | -0.04 | -0.04 |
2021-09-30 | -0.06 | -0.07 |
2021-06-30 | -0.08 | -0.10 |
2021-03-31 | -0.09 | -0.10 |
2020-12-31 | -0.10 | -0.12 |
2020-09-30 | -0.11 | -0.13 |
Efektivitas Manajemen
- roa untuk Touyun Biotech Group Limited pada 2025 Jun 30 adalah -0.15.
- roic untuk Touyun Biotech Group Limited pada 2025 Jun 30 adalah -0.26.
- croic untuk Touyun Biotech Group Limited pada 2025 Jun 30 adalah -0.05.
- ocroic untuk Touyun Biotech Group Limited pada 2025 Jun 30 adalah -0.15.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.15 | -0.26 | -0.05 | -0.15 | |
2025-03-31 | -0.15 | -0.26 | 0.00 | 0.00 | |
2024-12-31 | -0.38 | -4.18 | -0.64 | -0.07 | -0.12 |
2024-09-30 | -0.38 | -11.05 | -0.64 | -0.07 | -0.12 |
2024-06-30 | -0.36 | -1.23 | -0.39 | -0.14 | 0.01 |
2024-03-31 | -0.30 | -0.95 | -0.54 | -0.19 | 0.01 |
2023-12-31 | -0.22 | -0.82 | -0.28 | -0.05 | 0.03 |
2023-09-30 | -0.20 | -0.48 | -0.29 | 0.00 | 0.00 |
2023-06-30 | -0.20 | -0.48 | -0.28 | 0.01 | 0.07 |
2023-03-31 | -0.49 | -0.28 | 0.05 | 0.02 | |
2022-12-31 | -0.10 | -0.31 | -0.20 | 0.02 | 0.01 |
2022-09-30 | -0.10 | -0.20 | -0.20 | 0.02 | 0.01 |
2022-06-30 | -0.06 | -0.16 | -0.12 | -0.05 | 0.04 |
2022-03-31 | 0.00 | -0.14 | -0.20 | ||
2021-12-31 | -0.15 | -0.13 | -0.08 | -0.09 | -0.20 |
2021-09-30 | -0.11 | -0.20 | -0.12 | -0.07 | -0.20 |
2021-06-30 | -0.17 | -0.26 | -0.15 | -0.04 | -0.20 |
2021-03-31 | -0.18 | -0.28 | -0.16 | 0.03 | -0.11 |
2020-12-31 | -0.19 | -0.31 | -0.19 | 0.12 | -0.02 |
2020-09-30 | -0.21 | -0.35 | -0.22 | 0.10 | -0.06 |
Gross Margins
- marjin kotor untuk Touyun Biotech Group Limited pada 2025 Jun 30 adalah 0.45.
- marjin bersih untuk Touyun Biotech Group Limited pada 2025 Jun 30 adalah -0.55.
- marjin operasi untuk Touyun Biotech Group Limited pada 2025 Jun 30 adalah -0.29.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.45 | -0.55 | -0.29 |
2025-03-31 | 0.45 | -0.55 | -0.29 |
2024-12-31 | 0.30 | -1.37 | -0.53 |
2024-09-30 | 0.30 | -1.37 | -0.53 |
2024-06-30 | 0.27 | -1.35 | -0.45 |
2024-03-31 | 0.27 | -1.35 | -0.45 |
2023-12-31 | 0.38 | -0.77 | -0.24 |
2023-09-30 | 0.38 | -0.77 | -0.24 |
2023-06-30 | 0.38 | -0.77 | -0.24 |
2023-03-31 | 0.38 | -0.69 | -0.18 |
2022-12-31 | 0.36 | -0.47 | -0.13 |
2022-09-30 | 0.36 | -0.47 | -0.12 |
2022-06-30 | 0.38 | -0.32 | -0.12 |
2022-03-31 | -0.29 | -0.13 | |
2021-12-31 | 0.42 | -0.26 | -0.13 |
2021-09-30 | 0.42 | -0.41 | -0.14 |
2021-06-30 | 0.42 | -0.59 | -0.16 |
2021-03-31 | 0.41 | -0.69 | -0.21 |
2020-12-31 | 0.41 | -0.82 | -0.27 |
2020-09-30 | 0.37 | -0.83 | -0.22 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |